People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Genprex, Inc. | — | Biotechnology | Series A | $14.6M | $52.7M | 2019 |
Ryan M. Confer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ryan M. Confer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Friedman | 1 | 9 |
| John Rodney Varner | 1 | 2 |
| David E Friedman | 1 | 2 |
| Bob Rodney Pearson | 1 | 1 |
| David Rodney Friedman | 1 | 1 |
| Bob Pearson | 1 | 1 |
| Robert W. Pearson | 1 | 1 |
| Julien M. Pham | 1 | 1 |
| Julien Rodney Pham | 1 | 1 |
| Robert Rodney Pearson | 1 | 1 |
| Ryan Rodney Confer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.